By InvitationNot Applicable

Preservation of Venous Valvular Function After PMT for Acute DVT

China100 participantsStarted 2022-06-06

Plain-language summary

To evaluate the venous valvular function after pharmacomechanical thrombectomy (PMT) for acute femoral-popliteal venous thrombosis.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with acute symptomatic proximal DVT involving the femoral, and/or popliteal vein, common femoral vein, iliac veins (with or without other involved ipsilateral veins) were enrolled at seven vascular centers in China. Patients were treated with PCDT via Zelante device (Boston Scientific). Exclusion Criteria: * Participants were excluded if they had symptoms for more than 14 days.

What they're measuring

Valvular reflux prevalence

Timeframe: at 12 months after procedure

Trial details

NCT IDNCT05588284

SponsorShanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-12-30

View on ClinicalTrials.gov More Acute Deep Venous Thrombosis of Femoral Vein (Disorder) trials